Tyra Biosciences, Inc.

NASDAQ:TYRA

10.34 (USD) • At close April 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -86.481-69.134-55.325-26.294-9.336-4.065
Depreciation & Amortization 0.5190.3530.2960.140.0470.008
Deferred Income Tax 00000.0020
Stock Based Compensation 22.80113.52510.5882.8870.4390
Change In Working Capital -0.7296.36-5.847-0.4811.070.505
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.7449.3692.3571.4921.0190.461
Other Working Capital 0.015-3.009-8.204-1.9730.0510.044
Other Non Cash Items -5.884-1.2430.0030.0030.0150.934
Operating Cash Flow -69.774-50.139-50.285-23.745-7.763-2.618
Investing Activities:
Investments In Property Plant And Equipment -0.664-0.77-0.559-0.661-0.312-0.02
Acquisitions Net 0000.01600
Purchases Of Investments -263.624-143.8350000
Sales Maturities Of Investments 165.88500000
Other Investing Activites 000000
Investing Cash Flow -98.403-144.605-0.559-0.645-0.312-0.02
Financing Activities:
Debt Repayment 000-0.009-0.017-0.008
Common Stock Issued 2001.5370.632181.2223.4510.165
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 2.5571.5370.632130.13723.4510.165
Financing Cash Flow 202.1371.5370.001311.34823.4340.157
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 33.96-193.207-50.212286.95815.359-2.481
Cash At End Of Period 92.96659.006252.213302.42515.4670.108